Abstract: The invention relates to the compounds of formula I and formula II or its pharmaceutical acceptable salts, as well as polymorphs, solvates, enantiomers, stereoisomers and hydrates thereof. The pharmaceutical compositions comprising an effective amount of compounds of formula I or formula II, and methods for treating or preventing or modulating metabolic syndrome may be formulated for oral, buccal, rectal, topical, transdermal, transmucosal, intravenous, parenteral administration, syrup, or injection.

Abstract: In general, the invention relates to an algorithm and process for automated and/or continuous calibration of magnetic sensor, for example such as a sensor installed in a mobile positioning system handset. According to certain aspects, the calibration process can use the normal motion of the handset such that all measurement data from the three orthogonal axes of sensor when exposed to Earth's magnetic field is collected. According to still further aspects, the process includes fitting measurement data to an ellipsoid that characterizes the actual magnetic field measurements from a magnetic sensor, so that anomalies such as hard iron effect, soft iron effect and scale factors can be extracted and/or corrected by comparison to a sphere represented by magnetic field data from a model at the sensor's location.

Abstract: A system and method for increasing the vertical situational awareness of a pilot of a host aircraft, comprises rendering symbology on a vertical situation display of the host aircraft, the symbology comprising (1) a traffic scenario including at least the host aircraft and a second aircraft, the second aircraft involved in an ITP transition, and (2) flight level allocation data assigned to the second aircraft by air traffic control.

Abstract: Emulsion vaccine formulations containing an antigen and an adjuvant in the aqueous phase are used for the vaccination of animals wherein the adjuvant is an acrylic polymer and/or dimethyl dioctadecyl ammonium bromide (DDA). These formulations can be prepared by mixing an aqueous phase containing the antigen and adjuvant with an oil phase in the presence of an emulsifier.

Abstract: Various embodiments provide an ability to abstract type resolution between multiple type systems. At least one type can be described in one or more programmatically accessible file(s). In some embodiments, an application using a different type system can programmatically access and resolve a type of the at least one type system without knowledge of a location of where a description of the type resides. Alternately or additionally, type descriptions contained in the one or more programmatically accessible file(s) can be analyzed and restructured into one or more new programmatically accessible file(s) based, at least in part, upon the type descriptions.

Abstract: A method is provided in one example and includes receiving common format media including timed metadata associated with a timed metadata event. The method further includes extracting timed metadata information from the timed metadata, and generating a manifest corresponding to the common format media including the timed metadata information. The timed metadata information includes an indicator of a start time and an indicator of a duration of the timed metadata event. The method further includes generating a common format asset including the manifest.

Abstract: A flip-flop that includes a multiplexer configured to generate a multiplexer output. The multiplexer output is generated in response to an input and a scan enable, and is given to a transmission gate. A master latch is coupled to the transmission gate and to a tri-state inverter. The master latch is configured to receive an output of the transmission gate. A slave latch is configured to receive an output of the tri-state inverter and the multiplexer output. A data inverter is coupled to the slave latch. The data inverter is configured to generate a flip-flop output. A half clock gating inverter is configured to generate an inverted clock input in response to a clock input and the multiplexer output.

Abstract: The disclosure is directed to systems and methods for switching a data downloading session from a first mobile device to a second mobile device. The data downloading session first commences on the first mobile device. During the session, a download transfer condition is identified. In response, the first mobile device sends the second mobile device download resumption information, which is specifically adapted to enable the second mobile device to continue the data downloading session without having to restart an interrupted downloading operation.

Abstract: A multi layer interconnecting substrate has at least two spaced apart metal layers with a conductive pad on each one of the metal layers. Two different types of insulating layers are placed between the metal layers. The placement is such that one of the two different types of insulating layers is placed between the conductive pads and the other type of insulating layer is placed between the two spaced apart metal layers.

Abstract: Methods and systems for determining a numerical delay model based on one or more discretized delay models are described. A discretized delay model is a delay model in which the delay behavior is represented using a set of discrete data points of delay behavior. A numerical delay model is a delay model that can be used by a numerical solver to optimize a cost function. In general, computing delay using a numerical delay model is significantly faster than computing delay using discretized delay models. This performance improvement is important when optimizing a design for various metrics like timing, area and leakage power, because repeated delay computations are required in circuit optimization approaches.

Abstract: The present disclosure provides hetero-bicyclic compounds of formula (I), their tautomers, polymorphs, stereoisomers, prodrugs, solvates, hydrates, N-oxides, co-crystals, pharmaceutically acceptable salts, pharmaceutical compositions containing them and methods of treating conditions and diseases that are mediated by Bruton's tyrosine kinase (Btk) activity, The disclosure also relates to the process of preparation of compounds of Formula (I). These compounds are useful in the treatment, prevention, prophylaxis, management, or adjunct treatment of all medical conditions related to inhibition of Bruton's tyrosine kinase (Btk), such as inflammatory and/or autoimmune disorder, cell proliferation, rheumatoid arthritis, psoriasis, psoriatic arthritis, transplant rejection, graft-versus-host disease, multiple sclerosis, inflammatory bowel disease, allergic diseases, asthma, type 1 diabetes, myasthenia gravis, hematopoetic disfunction, B-cell malignancies, systemic lupus, erythematosus or other disorders.

Abstract: In an embodiment, an apparatus includes a consuming logic to request and process data including a critical data portion and a second data portion, the data stored in a memory coupled to a processor interposed between the apparatus and the memory. In addition, the apparatus includes a protocol stack logic coupled to the consuming logic to issue a read request to the memory via the processor to request the data and to receive a plurality of completions responsive to the read request. In an embodiment, the protocol stack logic includes a completion handling logic to send data of a first of the completions to the consuming logic before protocol stack processing is completed on the completions. Other embodiments are described and claimed.

Abstract: Techniques for handling errors on memory modules are provided. An uncorrected error from a pair of memory modules may be received. Memory modules other than the pair of memory modules producing the error may be de-configured. Diagnostic tests may be run on the faded pair of memory modules. The memory module of the pair of memory modules that caused the uncorrected error may be determined.

Abstract: A bonding pad and a method of manufacturing a bonding pad are presented. The method includes providing a substrate prepared with circuits component and an interlevel dielectric (ILD) layer with interconnects. A final passivation level is formed on the substrate surface and includes a pad opening. A wire bond in contact with the pad interconnect is formed in the pad opening. The pad interconnect is suitable for, for example, copper wire bond and can avoid the formation of intermetallic compound during wire bonding. This Abstract is submitted with the understanding that it will not be used to interpret or limit the scope or meaning of the claims.

Abstract: Pharmaceutical compositions and dosage forms for administration of hydrophobic drugs are provided. The pharmaceutical compositions include a therapeutically effective amount of a hydrophobic drug, preferably a steroid; a solubilizer, and a surfactant. The synergistic effect between the hydrophobic drug and the solubilizer results in a pharmaceutical formulation with improved dispersion of both the active agent and the solubilizer. As a result of the improved dispersion, the pharmaceutical composition has improved bioavailability upon administration. Methods of improving the bioavailability of hydrophobic drugs administered to a patient are also provided.

Abstract: The present disclosure relates to substituted amide compounds that are inhibitors of Fatty Acid Amide Hydrolase (FAAH), their stereoisomers, tautomers, prodrugs, polymorphs, solvates, pharmaceutically acceptable salts, and pharmaceutical compositions containing them.

Abstract: A catalyst substrate module for an exhaust aftertreatment system is provided. The catalyst substrate module comprises an outer containment wall, an inner containment wall, a first bar, a second bar, a first substrate element, a second substrate element, and a center member. The outer containment wall and the inner containment wall are co-planar and aligned along a common centerline. The first bar and the second bar are coupled to an inner face of the outer containment wall. The first substrate element is enclosed within an inner face of the inner containment wall and the second substrate element is captured within a space defined by the inner containment wall and the outer containment wall. Further, the center member extends along the centerline of the inner containment.

Abstract: A flexible system for collecting and reporting instrumentation metrics relating to performance of a software product. Computing devices that execute the software product receive a manifest that specifies the manner in which instrumentation metrics are collected and reported, including what instrumentation metrics are collected. Based on the manifest, an instrumentation metrics client associated with a software product may retrieve instrumentation data from a software product or other sources. The metrics client may then generate one or more instrumentation metrics, based on the instrumentation data, in accordance with instructions in the manifest. The metrics client may then take one or more actions based on the instrumentation metrics and the manifest, such as reporting the information to an instrumentation metrics server for aggregation and analysis by the metrics server or performing escalation actions that can modify the metrics collected and reported.

Abstract: A method of automating patching of a computer system includes determining whether a computer patch is available for a computer system of a customer, determining a patch management policy of the customer, determining a patch window of the customer based on the determined patch management policy, and directing application of the computer patch to the computer system at the determined patch window.

Abstract: An application programming interface is provided that allows applications to assign multiple service-level agreements to their data transactions. The service-level agreements include latency bounds and consistency guarantees. The applications may assign utility values to each of the service-level agreements. A monitor component monitors the various replica nodes in a cloud storage system for latency and consistency, and when a transaction is received from an application, the monitor determines which of the replica nodes can likely fulfill the transaction in satisfaction of any of the service-level agreements. Where multiple service-level agreements can be satisfied, the replica node that can fulfill the transaction according to the service-level agreement with the greatest utility is selected. The application may be charged for the transaction based on the utility of the service-level agreement that was satisfied.